GMED
GMED
US · Stock · NYSE/NASDAQ
$76.49
Pre-Market · NYSE/NASDAQ
AIQ Score (0-100)
55
/100
NEUTRAL
Smart Score (1-10)
7 /10
Momentum34
Value53
Quality72
Risk63
Current market regime: Neutral

In a Neutral regime, GMED's AIQ Score of 55/100 with Quality base of 72/100 and accelerating Momentum at 34/100 (Δ+2) signals mixed conviction. Wait for component alignment before adding exposure. Watch momentum trend for confirmation or fading.

Signal conflict detected

Quality (72/100) leads while Momentum (34/100) lags. This cross-factor spread creates entry timing uncertainty. Wait for the lagging factor to begin recovering before adding aggressively.

Why GMED scores 55 — top signal drivers
Death Cross Active
high-impact trend signal at 4.91% warning of downside pressure: Death Cross Active.
bearish+76.00%
ATR Expansion - Breakout Mode
medium-impact volatility signal at 3.81% worth monitoring: ATR Expansion - Breakout Mode.
neutral+68.00%
Downtrend Structure Active
medium-impact trend signal at 76.49 warning of downside pressure: Downtrend Structure Active.
bearish+68.00%
MACD Bearish Crossover
low-impact momentum signal at -1.2284 warning of downside pressure: MACD Bearish Crossover.
bearish+61.00%
Other·sector move·Market context unavailable.

Quick Stats

Market Cap
P/E Ratio
P/B Ratio
Dividend Yield
Beta
Volume
52W High
52W Low
Evidence Receipts + Persistence
AIQ score today
55/100
Neutral
30-day Avg AIQ
58/100
+3 vs today — trending down
Days with AIQ ≥ 60 (last 60)
11 of 60 trading days
Strongest driver
Quality 72/100 — constructive
Binding constraint
Momentum 34/100 — weak
7-day momentum Δ
+2 pts — stable
AIQ Score Change Narrative

GMED's 7-day signal profile is largely stable with AIQ change of +1.0 points and momentum delta of +2.0. Trend delta is +1.00, which helps frame whether the current move is accelerating or fading.

Snapshot: Sun, 26 Jul 2026 00:00:00 GMT. Baseline: 2026-07-17.

AIQ Δ7d: +1.0Momentum Δ7d: +2.0Value Δ7d: 0.0Quality Δ7d: 0.0Risk Δ7d: +3.0Trend Δ7d: +1.00
Weekly Score Historymethodology →
DateAIQMomValQualResilience
2026-07-255534537263
2026-07-185432537260
2026-07-115739537262
2026-07-045741537262
2026-06-276776537269
Recent News
See all news
Sentiment —
No recent news found for GMED

GMED (GMED) Stock Analysis

Snapshot summary of AIQ score, trend, and risk context.

GMED (GMED) has an AIQ Score of 55/100 in a Neutral regime as of Jul 25, 2026. Quality is strongest at 72/100. Momentum is weakest at 34/100. The main conflict is that quality leads at 72/100 while momentum lags at 34/100.

GMED (GMED) carries an AIQ Score of 55 out of 100, placing it in a mixed signal regime for this snapshot. A mid-range reading typically means component signals are not fully aligned, so interpretation should focus on what is improving versus what is lagging.

Beta is 1.07, implying roughly 7% higher sensitivity than a broad market baseline.

In the latest weekly profile, AIQ has moved +1.0 points over the last 7 days, momentum delta is +2.0, trend delta is +1.00, risk delta is +3.0. This combination is most useful for judging whether signal quality is strengthening or fading into mean reversion.

Evidence LayerPublic Evidence
Regime ContextGMED is in a Neutral AIQ regime with score 55/100.
Signal ConflictThe primary conflict is that quality leads at 72/100 while momentum lags at 34/100.
Factor EvidenceMomentum 34/100 · Value 53/100 · Quality 72/100 · Risk 63/100
PersistenceGMED has scored AIQ 60+ in 11 of the last 60 daily snapshots. 30-day avg: 58/100. 60-day avg: 58/100.
ChecklistStatusEvidence
Factor strengthPassQuality is the strongest factor at 72/100.
TimingFailMomentum is 34/100 with 7-day delta +2.0.
Regime fitWaitGMED is in a Neutral regime at 55/100.
Risk controlWaitRisk factor is 63/100 with beta of 1.07 suggests market-like sensitivity.
ConflictWaitCurrent conflict: quality leads at 72/100 while momentum lags at 34/100.
AIQ 60+ snapshots: 11/60
30-snapshot avg: 58/100
60-snapshot avg: 58/100
What Changed Recently (GMED)

GMED's 7-day signal profile is largely stable with AIQ change of +1.0 points and momentum delta of +2.0. Trend delta is +1.00, which helps frame whether the current move is accelerating or fading.

Signal snapshot as of Sun, 26 Jul 2026 00:00:00 GMT. 7-day comparison baseline: 2026-07-17.

AIQ Δ7d: +1.0
Momentum Δ7d: +2.0
Value Δ7d: 0.0
Quality Δ7d: 0.0
Risk Δ7d: +3.0
Trend Δ7d: +1.00
MetricCurrent
AIQ Score55/100
Price$76.49
Beta1.07

GMED vs Medical Devices Peers

GMED ranks 3 of 5 in this peer set. Full sector ranking →
Compare Stocks
SymbolAIQSmartVerdict
INSP6610Neutral
HOLX578Neutral
GMED557Neutral
HAYW536Neutral
IDXX484Neutral

Portfolio Implication

GMED currently shows balanced but still concentration-sensitive risk. Beta is currently unavailable, so position sizing should be reviewed with scenario analysis.

GMED Stock FAQ

What does the GMED AIQ Score mean?

AIQ Score summarizes multiple factors for GMED, including momentum, value, quality, and risk. Higher scores generally indicate stronger combined signals, but you should still validate with your own risk tolerance.

How often is GMED data updated?

GMED quote and scoring components refresh on the platform cadence. Always confirm timestamp freshness on-page before making time-sensitive decisions.

Should I compare GMED with an index before investing?

Yes. Comparing GMED versus benchmarks like SPY or QQQ helps you separate stock-specific strength from broader market moves.

Where can I review deeper GMED fundamentals, technicals, and risk?

Use the Fundamentals, Technicals, and Risk tabs from this page to inspect driver-level metrics behind the headline score.

How the AIQ Score Is Built

Methodology, factor weights, and how to interpret score history

Read the methodology →

Loading GMED...

© 2026 AlgoVestIQTermsPrivacyRisk Disclosure

Informational only, not investment advice. Investing involves risk, including loss of principal.